Literature DB >> 20948290

Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?

Chi V Dang1.   

Abstract

A cancer cell comprising largely of carbon, hydrogen, oxygen, phosphorus, nitrogen and sulfur requires not only glucose, which is avidly transported and converted to lactate by aerobic glycolysis or the Warburg effect, but also glutamine as a major substrate. Glutamine and essential amino acids, such as methionine, provide energy through the TCA cycle as well as nitrogen, sulfur and carbon skeletons for growing and proliferating cancer cells. The interplay between utilization of glutamine and glucose is likely to depend on the genetic make-up of a cancer cell. While the MYC oncogene induces both aerobic glycolysis and glutaminolysis, activated β-catenin induces glutamine synthesis in hepatocellular carcinoma. Cancer cells that have elevated glutamine synthetase can use glutamate and ammonia to synthesize glutamine and are hence not addicted to glutamine. As such, cancer cells have many degrees of freedom for re-programming cell metabolism, which with better understanding will result in novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20948290     DOI: 10.4161/cc.9.19.13302

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  111 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.

Authors:  Pratima Tripathi; Pachiyappan Kamarajan; Bagganahalli S Somashekar; Neil MacKinnon; Arul M Chinnaiyan; Yvonne L Kapila; Thekkelnaycke M Rajendiran; Ayyalusamy Ramamoorthy
Journal:  Int J Biochem Cell Biol       Date:  2012-06-26       Impact factor: 5.085

3.  Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.

Authors:  Marcel Cetindis; Thorsten Biegner; Adelheid Munz; Peter Teriete; Siegmar Reinert; Martin Grimm
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

4.  An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.

Authors:  Aya Osanai-Sasakawa; Kenta Hosomi; Yoshiki Sumitomo; Takuya Takizawa; Shiho Tomura-Suruki; Minami Imaizumi; Noriyuki Kasai; Tze Wei Poh; Kazuya Yamano; Wei Peng Yong; Koji Kono; Satoshi Nakamura; Toshihiko Ishii; Ryuichiro Nakai
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.

Authors:  Shuo Qie; Clarissa Chu; Weihua Li; Chenguang Wang; Nianli Sang
Journal:  J Cell Biochem       Date:  2014-03       Impact factor: 4.429

Review 6.  Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night.

Authors:  Robin Mathew; Eileen White
Journal:  Curr Opin Genet Dev       Date:  2011-01-20       Impact factor: 5.578

7.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 8.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

9.  Normoxic accumulation of HIF1α is associated with glutaminolysis.

Authors:  Matthias Kappler; Ulrike Pabst; Swetlana Rot; Helge Taubert; Henri Wichmann; Johannes Schubert; Matthias Bache; Claus Weinholdt; Uta-Dorothee Immel; Ivo Grosse; Dirk Vordermark; Alexander W Eckert
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

10.  Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.

Authors:  Yi-Ying Lee; Chien-Feng Li; Ching-Yih Lin; Sung-Wei Lee; Ming-Jen Sheu; Li-Ching Lin; Tzu-Ju Chen; Ting-Feng Wu; Chung-Hsi Hsing
Journal:  Tumour Biol       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.